MK-677, also known as Ibutamoren, is a growth hormone secretagogue that stimulates the pituitary gland to release more growth hormone (GH) and insulin-like growth factor 1 (IGF-1). While technically not a peptide — it's a non-peptide ghrelin receptor agonist — MK-677 is frequently grouped alongside peptides in research protocols because of its GH-boosting mechanism. What sets it apart from injectable GH secretagogues like Ipamorelin or CJC-1295 is that MK-677 is orally active, meaning no reconstitution or injections are required.
This guide covers the standard MK-677 dosage ranges used in research settings, how timing affects results, recommended cycling protocols, and the side effects and bloodwork markers you should be aware of before starting a protocol.
How MK-677 Works: Mechanism of Action
MK-677 mimics the hormone ghrelin by binding to the ghrelin receptor (GHSR) in the brain. This triggers a pulsatile release of growth hormone from the anterior pituitary, closely mimicking the body's natural GH secretion pattern. Unlike exogenous HGH, which floods the system with a flat dose, MK-677 preserves the natural peaks and troughs of GH release.
Studies indicate that MK-677 elevates GH and IGF-1 levels for up to 24 hours after a single oral dose, which is why once-daily dosing is the standard protocol. Research also suggests that MK-677 does not significantly suppress the hypothalamic-pituitary axis, meaning it doesn't cause the same negative feedback loop that exogenous GH can create.
Standard MK-677 Dosage Ranges
The dosing range most commonly referenced in clinical research and protocol guides falls between 10mg and 25mg per day, taken orally. Here is a breakdown of typical dosing tiers:
| Dose Level | Daily Dose | Typical Use Case | Notes |
|---|---|---|---|
| Low | 10 mg | Improved sleep quality, mild GH elevation | Fewest side effects; good starting point |
| Moderate | 15 mg | Balance of GH elevation and tolerability | Most commonly referenced dose in studies |
| Standard | 20 mg | Significant IGF-1 increase, recovery support | Hunger and water retention more noticeable |
| High | 25 mg | Maximum GH secretion studied | Diminishing returns above 25mg; more side effects |
Research published in the Journal of Clinical Endocrinology & Metabolism found that 25mg daily raised IGF-1 levels by approximately 60% over baseline in healthy subjects. However, 10-15mg doses still produced meaningful GH elevation with far fewer adverse effects, making them the preferred starting range in most protocols.
Timing: When to Take MK-677
Because MK-677 has a long half-life of approximately 24 hours, it only needs to be dosed once daily. However, the time of day you take it can influence your experience with certain side effects.
Before Bed (Most Common)
Taking MK-677 30-60 minutes before sleep is the most widely recommended timing. Growth hormone naturally peaks during deep sleep, and MK-677 amplifies this effect. Dosing at night also means that the two most common early side effects — increased hunger and mild lethargy — occur while you're sleeping rather than during your active hours.
Morning Dosing
Some protocols call for morning dosing, particularly when the goal is elevated IGF-1 throughout the day. The trade-off is that the appetite increase from ghrelin receptor activation hits during waking hours, which can make it harder to manage caloric intake. Morning dosing may suit those who want the hunger-stimulating effect to support a caloric surplus.
Understanding how half-life affects your protocol timing is crucial. Our guide on peptide half-lives and why timing matters covers this topic in depth across different compounds.
MK-677 Cycling Protocols
While some research studies have administered MK-677 continuously for up to 12 months, most protocol guides recommend cycling to manage side effects and maintain receptor sensitivity. Here are the most commonly used cycling frameworks:
| Cycle Type | On Period | Off Period | Best For |
|---|---|---|---|
| Standard Cycle | 8 weeks | 4 weeks | First-time users; conservative approach |
| Extended Cycle | 12 weeks | 4-6 weeks | Experienced users with good bloodwork |
| 5-on / 2-off (Weekly) | 5 days | 2 days | Minimizing water retention and blood sugar impact |
The standard 8-12 weeks on, 4 weeks off cycle is the most widely referenced. The off period allows insulin sensitivity to normalize and reduces the potential for prolonged IGF-1 elevation, which some researchers prefer to avoid over extended timeframes.
Side Effects to Monitor
MK-677 is generally well-tolerated in clinical research, but several side effects deserve attention, particularly during the first 2-4 weeks of a protocol.
Increased Appetite
Because MK-677 activates the ghrelin receptor, it stimulates hunger — sometimes significantly. This effect is most pronounced in the first few weeks and tends to diminish as the body adjusts. Dosing before bed helps mitigate this for many users.
Water Retention and Bloating
Elevated GH levels cause increased sodium and water retention. Mild puffiness, particularly in the hands and face, is commonly reported. This typically stabilizes after 3-4 weeks. Maintaining adequate water intake and monitoring sodium consumption can help manage this effect.
Blood Sugar and Insulin Sensitivity
This is the most important side effect to monitor. Studies indicate that MK-677 can reduce insulin sensitivity and raise fasting blood glucose levels. In a 12-month study, fasting glucose increased modestly but remained within normal range for most healthy subjects. However, individuals with pre-existing insulin resistance or a family history of diabetes should exercise particular caution.
Lethargy and Vivid Dreams
Some protocols note increased drowsiness, especially at higher doses, along with intensely vivid dreams. This is likely related to the deeper sleep cycles promoted by elevated GH during the night.
Bloodwork Recommendations for MK-677 Protocols
Anyone running an MK-677 protocol should get bloodwork done at three key points: before starting (baseline), at the 4-6 week mark, and after completing the cycle. The following markers are essential:
| Marker | Why It Matters | Target Range |
|---|---|---|
| IGF-1 | Confirms MK-677 is elevating GH output | Age-adjusted normal to moderately elevated |
| Fasting Glucose | Detects blood sugar elevation early | 70-100 mg/dL |
| HbA1c | Shows 3-month average blood sugar | Below 5.7% |
| Fasting Insulin | Measures insulin resistance trends | 2-15 mIU/L |
| Prolactin | Some reports of mild elevation on MK-677 | Male: 2-18 ng/mL; Female: 2-29 ng/mL |
If fasting glucose rises above 100 mg/dL or HbA1c trends upward, most protocol guides recommend reducing the dose or discontinuing the cycle. Keeping a detailed log of your dosing, timing, and how you feel each day makes it much easier to correlate bloodwork changes with your protocol. Our guide on how to track your peptide protocol outlines a simple system for this.
MK-677 vs. Injectable GH Secretagogues
One of the most common questions is how MK-677 compares to injectable GH-releasing peptides. Here is a practical comparison:
| Factor | MK-677 (Oral) | Injectable Secretagogues (e.g., Ipamorelin) |
|---|---|---|
| Administration | Oral capsule or liquid | Subcutaneous injection |
| Frequency | Once daily | 1-3 times daily |
| Reconstitution Needed | No | Yes |
| Half-Life | ~24 hours | ~2 hours (varies by compound) |
| Appetite Stimulation | Significant (ghrelin agonist) | Minimal |
| Blood Sugar Impact | Moderate concern | Minimal |
Frequently Asked Questions
Can MK-677 be taken with food or does it need to be taken on an empty stomach?
MK-677 can be taken with or without food. Its oral bioavailability is not significantly affected by food intake. However, some protocol guides suggest taking it on an empty stomach before bed for slightly faster absorption. If MK-677 causes stomach discomfort, taking it with a small meal is a reasonable adjustment.
How long does it take to see elevated IGF-1 levels on MK-677?
Studies indicate that GH levels begin rising within hours of the first dose, and IGF-1 levels show measurable increases within 1-2 weeks. Peak IGF-1 elevation is typically observed at the 4-6 week mark of consistent daily dosing.
Does MK-677 suppress natural growth hormone production?
Research suggests that MK-677 does not suppress the body's natural GH axis in the same way that exogenous HGH does. Because it works by stimulating the pituitary rather than replacing its output, the natural feedback loop remains largely intact. This is one of the key advantages of secretagogues over direct GH administration.
Is PCT (post-cycle therapy) required after an MK-677 cycle?
MK-677 does not affect testosterone or other sex hormones, so traditional PCT is not required. The main consideration during the off period is allowing insulin sensitivity to normalize. Monitoring fasting glucose and HbA1c after completing a cycle is recommended.
Sources and References
- Pong SS, et al. "Identification of a new G-protein-linked receptor for growth hormone secretagogues." Mol Endocrinol. 1996.
- Chapman IM, et al. "Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects." J Clin Endocrinol Metab. 1996.
- Nass R, et al. "Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial." Ann Intern Med. 2008.
- Murphy MG, et al. "MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism." J Clin Endocrinol Metab. 1998.
- Sigalos JT, Pastuszak AW. "The Safety and Efficacy of Growth Hormone Secretagogues." Sex Med Rev. 2018.